Thursday, 5 November 2026European Markets

SLIGRO FOOD GROUP And B&S Group Have A High Dividend Yield And Return On Equity In The Food Distribution Industry.

Loading stream...

(VIANEWS) - SLIGRO FOOD GROUP (SLIGR.AS) is among this list of stock assets with the highest dividend rate and return on equity on the Food Distribution industry.

Financial Asset Price Forward Dividend Yield Return on Equity
SLIGRO FOOD GROUP (SLIGR.AS) €13.44 4.34% 1.28%
B&S Group (BSGR.AS) €4.80 3.35% 16.93%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SLIGRO FOOD GROUP (SLIGR.AS)

4.34% Forward Dividend Yield and 1.28% Return On Equity

Sligro Food Group N.V. engages in the foodservice businesses in the Netherlands and Belgium. The company offers a range of food and food-related non-food products; and services in the food and beverages wholesale market. It operates a network of cash-and-carry and delivery service sites to serve hospitality industry, leisure facilities, caterers, large-volume users, company restaurants, petrol stations, small and medium-sized enterprises, small retail businesses, and the institutional markets under the Sligro, De Kweker, and Van Hoeckel brand names in the Netherlands. It also serves institutional, corporate catering, and hotel chain segments under the JAVA Foodservice name; and hospitality industry, culinary professionals, and wholesale delivery service outlets under the Sligro-ISPC and Sligro-M name through a network of cash-and-carry and delivery service sites. In addition, the company is involved in the production of convenience and fresh fish products; sourcing of meat, game and poultry, fruits and vegetables, and bread and pastries; advertise, design, delivery, install, and maintenance of professional kitchen, kitchen equipment, appliances, and refrigeration and freezing equipment; and provision of online gift concepts and Christmas gifts, and traditional Christmas hampers. It also offers its products through online platform. Sligro Food Group N.V. was founded in 1935 and is headquartered in Veghel, the Netherlands.

Earnings Per Share

As for profitability, SLIGRO FOOD GROUP has a trailing twelve months EPS of €0.14.

PE Ratio

SLIGRO FOOD GROUP has a trailing twelve months price to earnings ratio of 96. Meaning, the purchaser of the share is investing €96 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.28%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SLIGRO FOOD GROUP's stock is considered to be overbought (>=80).

Volatility

SLIGRO FOOD GROUP's last week, last month's, and last quarter's current intraday variation average was a negative 0.30%, a negative 0.39%, and a positive 0.84%.

SLIGRO FOOD GROUP's highest amplitude of average volatility was 0.99% (last week), 0.88% (last month), and 0.84% (last quarter).

Yearly Top and Bottom Value

SLIGRO FOOD GROUP's stock is valued at €13.44 at 07:40 EST, way under its 52-week high of €18.30 and above its 52-week low of €13.00.

More news about SLIGRO FOOD GROUP.

2. B&S Group (BSGR.AS)

3.35% Forward Dividend Yield and 16.93% Return On Equity

B&S Group S.A. distributes consumer goods worldwide. The company operates through six segments: Liquors, Beauty, Personal Care, Food, Health, and Travel Retail. The Liquors segment distributes branded liquors to wholesalers, consumers, and e-commerce platforms. The Beauty segment distributes and sells branded fragrances and cosmetics to wholesalers, consumers, and e-commerce platforms. The Personal Care segment distributes and sells branded personal and home care products to retailers. The Food segment distributes a range of branded food and beverages products to duty-free, remote, retail, and maritime markets. The Health segment distributes and sells branded medical products and equipment to maritime and remote markets, pharmacies, and travel clinics. The Travel Retail segment operates retail stores at international and regional airports and offers consumer electronics and multi-category assortments for consumers at travel locations. The company was founded in 1872 and is based in Betzdorf, Luxembourg.

Earnings Per Share

As for profitability, B&S Group has a trailing twelve months EPS of €0.24.

PE Ratio

B&S Group has a trailing twelve months price to earnings ratio of 20. Meaning, the purchaser of the share is investing €20 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.93%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 2.22B for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 28, 2024, the estimated forward annual dividend rate is 0.16 and the estimated forward annual dividend yield is 3.35%.

More news about B&S Group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com